Precision medicine is transforming the hematology-oncology clinical landscape, offering tailored treatments to the unique genetic and molecular profiles of patients. From advanced detection technologies to breakthrough therapies like CAR T and bispecific antibodies, these innovative approaches present new hope for tackling complex blood cancers.
Read our guide to explore:
- The role of biomarkers in treatment optimization and patient selection
- Advanced detection technologies, including liquid biopsy and single-cell sequencing
- Challenges in implementing precision medicine and actionable solutions
- Future innovations, such as multi-specific antibodies and CRISPR